SHARE facebook twitter 닫기 PRINT 공지사항 [관련기사]IASLC 2017: Poziotinib Yields High Response Rates in Patients With NSCLC With EGFR Exon 20 Insertion By The ASCO Post 2017-10-24722 일시 : 2017.10.20. 기관 : ASCO POST IASLC 2017: Poziotinib Yields High Response Rates … [상세보기] 목록 Prev[행사안내]NOV-FEBPS Anti-Cancer Symposium Next[공고]제17-2차 후보물질 공모 안내